Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0001030575-26-000004

Director sold 171,405 shares at an average $14.34 ($2,458,582)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

FORMELA JEAN FRANCOIS · Director

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-22 Sale : show line 1 in the form 10b5-1 −3,382 $13.95 $47,179 936,252 I
2026-06-22 Sale : show line 2 in the form 10b5-1 −580 $13.95 $8,091 194,075 I
2026-06-23 Sale : show line 3 in the form 10b5-1 −101,579 $14.25 $1,447,501 834,673 I
2026-06-23 Sale : show line 4 in the form 10b5-1 −17,426 $14.25 $248,321 176,649 I
2026-06-24 Sale : show line 5 in the form 10b5-1 −40,679 $14.60 $593,913 793,994 I
2026-06-24 Sale : show line 6 in the form 10b5-1 −666 $14.98 $9,977 793,328 I
2026-06-24 Sale : show line 7 in the form 10b5-1 −6,979 $14.60 $101,893 169,670 I
2026-06-24 Sale : show line 8 in the form 10b5-1 −114 $14.98 $1,708 169,556 I
Open-market sales · 171,405 sh · avg $14.34 · $2,458,582
Loading xslF345X06/form4-06252026_120611.xml…